PULSE BIOSCIENCES, INC.

For the period ended Sep 30, 2026. Filed Nov 5, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 5, 2026

PLSE$58.17+9.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

(In thousands, except share and per share data)

	September 30,	December 31,
	2026	2025
ASSETS
Current assets:
Cash and cash equivalents	$36,725	$80,735
Marketable securities	152,469	—
Accounts receivable	297	274
Inventory	232	136
Prepaid expenses and other current assets	2,485	2,276
Total current assets	192,208	83,421
Property and equipment, net	1,073	1,051
Intangible assets, net	55	575
Goodwill	2,791	2,791
Right-of-use assets	5,059	6,010
Other assets	398	691
Total assets	$201,584	$94,539
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$3,018	$2,777
Accrued liabilities	8,630	3,576
Lease liability, current	1,747	1,570
Total current liabilities	13,395	7,923
Lease liability, less current portion	4,616	5,960
Total liabilities	18,011	13,883
Stockholders’ equity:
Preferred stock, $0.001 par value; authorized – 50,000,000 shares; no shares issued and outstanding	—	—
Common stock, $0.001 par value; authorized – 500,000,000 shares; issued and outstanding – 73,314,797 shares and 67,839,689 shares as of September 30, 2026 and December 31, 2025, respectively	73	68
Additional paid-in capital	713,153	543,869
Accumulated other comprehensive loss	(83)	—
Accumulated deficit	(529,570)	(463,281)
Total stockholders’ equity	183,573	80,656
Total liabilities and stockholders’ equity	$201,584	$94,539

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.